Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ACS news flash: Agouron investigates CDK inhibitors as anticancer agents

Aug. 27, 1999

Highly stable and lipophilic camptothecin derivatives prepared at Tigen

Aug. 27, 1999

P-SCN-Bz-HEHA, a bifunctional chelating agent designed to enable use of Ac-225 in radioimmunotherapy

Aug. 26, 1999

Highlights from ACS: integrin antagonist SC-72115 is a potent angiogenesis inhibitor in vivo

Aug. 26, 1999

Cytoskeleton employs novel HTS assay to identify new tubulin ligands

Aug. 26, 1999

British Biotech reports results of marimastat Study 145 in gastric cancer

Aug. 26, 1999

Bioniche's IND for bladder cancer treatment granted IND approval

Aug. 25, 1999

Procept announces NCI-sponsored trials of its chemosensitizing agent

Aug. 24, 1999

Merck KGaA's novel vitronectin antagonist EMD-121974 enters clinical testing in various cancers

Aug. 24, 1999

FDA Advisory Committee to review Evacet on September 16

Aug. 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.